News – Page 68 – Endpoints News

Daiichi's $150M build in China; BioMarin reveals €60M Irish expansion

5 months ago

Eli Lilly and Ro’s unlikely relationship

5 months ago

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

5 months ago

Recapping the Endpoints 100: The biotech industry braces itself for Trump 2.0

5 months ago

Pfizer shares positive Phase 3 results in breast cancer subset

5 months ago

Keros halts parts of Phase 2 PAH trial due to safety, stock tanks 70%

5 months ago

Pleno raises $25M for multiomics testing, names new CEO

5 months ago

Healthcare veteran Glen Tullman thinks AI implementation will define health tech in 2025

5 months ago

Corcept’s ALS drug fails to improve function in Phase 2 study

5 months ago

Lonza looks to depart capsule and health ingredients as it undergoes restructure

5 months ago

The brain is Eli Lilly's next target for its obesity meds

5 months ago

During Covid, RFK Jr. lobbied against vaccine EUAs for children. As HHS secretary, he could rescind them

5 months ago

Drugs are approved — and made available — faster in US than most of EU, data show

5 months ago

NIH halts enrollment in trial for SIGA's mpox antiviral after disappointing data

5 months ago

Candel’s shares soar on Phase 3 prostate cancer data despite unclear prospects

5 months ago

Post-Hoc: Trying to make sense of a killing

5 months ago

Relay Therapeutics plans pivotal trial in second-line breast cancer for 2025

5 months ago

BenevolentAI restructures; Cimeio, Kyowa ink cell therapy deal

5 months ago

Gene editing companies seek safer, less grueling conditioning methods for blood stem cell therapies

5 months ago

Acelyrin says goodbye to the drug that got it a $540M IPO in 2023

5 months ago

Eli Lilly has tapped telehealth startup Ro to distribute its single-dose Zepbound vials

5 months ago

Lilly’s oral SERD makes strides in breast cancer with Phase 3 data

5 months ago

Q32 Bio’s stock crashes after atopic dermatitis fail, alopecia trial snafu

5 months ago

The Endpoints 100: The biotech industry braces for Trump 2.0

5 months ago

First page Previous page 65 66 676869 70 71 Next page Last page